Mycophenolat-Natrium ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
66IgA nephropathy1

66. IgA nephropathy


Clinical trials : 255 Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-000443-99-DE
(EUCTR)
09/04/200813/11/2008Comparison of the sequential maintenance therapy with Mycophenolat and Prednisolon to standard therapy after completed induction therapy – a multicenter, randomised, phase III intervention study for progressive IgA-Nephritis Comparison of the sequential maintenance therapy with Mycophenolat and Prednisolon to standard therapy after completed induction therapy – a multicenter, randomised, phase III intervention study for progressive IgA-Nephritis progressive IgA-Nephritis
MedDRA version: 9.1;Level: LLT;Classification code 10029143;Term: Nephritis-glomerular
Trade Name: Myfortic
INN or Proposed INN: Mycophenolat-Natrium
Trade Name: Decortin H
INN or Proposed INN: Prednisolon
Universitätsklinikum UlmNULLNot RecruitingFemale: yes
Male: yes
Phase 3Germany